- Home
- NVEC vs MIST Comparison
NVEC vs MIST Comparison
Compare NVEC & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVEC
- MIST
- Stock Information
- Founded
- NVEC 1989
- MIST 2003
- Country
- NVEC United States
- MIST Canada
- Employees
- NVEC N/A
- MIST 33
- Industry
- NVEC Semiconductors
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- NVEC Technology
- MIST Health Care
- Exchange
- NVEC Nasdaq
- MIST Nasdaq
- Market Cap
- NVEC 282.2M
- MIST 53.9M
- IPO Year
- NVEC 1996
- MIST N/A
- Fundamental
- Price
- NVEC $58.47
- MIST $1.28
- Analyst Decision
- NVEC
- MIST Strong Buy
- Analyst Count
- NVEC 0
- MIST 2
- Target Price
- NVEC N/A
- MIST $9.50
- AVG Volume (30 Days)
- NVEC 29.6K
- MIST 3.7M
- Earning Date
- NVEC 05-05-2025
- MIST 05-12-2025
- Dividend Yield
- NVEC 6.89%
- MIST N/A
- EPS Growth
- NVEC N/A
- MIST N/A
- EPS
- NVEC 3.10
- MIST N/A
- Revenue
- NVEC $25,688,208.00
- MIST N/A
- Revenue This Year
- NVEC N/A
- MIST N/A
- Revenue Next Year
- NVEC N/A
- MIST N/A
- P/E Ratio
- NVEC $18.86
- MIST N/A
- Revenue Growth
- NVEC N/A
- MIST N/A
- 52 Week Low
- NVEC $51.50
- MIST $0.63
- 52 Week High
- NVEC $89.98
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- NVEC 44.47
- MIST 54.17
- Support Level
- NVEC $55.48
- MIST $1.09
- Resistance Level
- NVEC $59.31
- MIST $0.88
- Average True Range (ATR)
- NVEC 2.99
- MIST 0.10
- MACD
- NVEC 0.39
- MIST 0.09
- Stochastic Oscillator
- NVEC 68.00
- MIST 94.24
About NVEC NVE Corporation
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).